Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland

European Urology

Volumn 60, Issue 3, 2011, Pages 458-464

  Weight, Christopher J ^a   Kim, Simon P ^a   Lohse, Christine M ^a   Cheville, John C ^a   Thompson, R Houston ^a   Boorjian, Stephen A ^a   Leibovich, Bradley C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adrenalectomy; Partial nephrectomy; Radical nephrectomy; Renal cell cancer; Survival

Indexed keywords

ADRENAL METASTASIS; ADRENALECTOMY; ADULT; ADVANCED CANCER; AGED; ARTICLE; ASYNCHRONOUS ADRENAL METASTASIS; CANCER RISK; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRECTOMY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR THROMBUS; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINNESOTA; NEOPLASM INVASIVENESS; NEPHRECTOMY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960995076     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.04.022     Document Type: Article

References (24)

1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297-301.
2. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971;28:1165-77.
3. Angervall L, Wahlqvist L. Follow-up and prognosis of renal carcinoma in a series operated by perifascial nephrectomy combined with adrenalectomy and retroperitoneal lymphadenectomy. Eur Urol 1978;4:13-7. (Pubitemid 8266878)
4. Mickisch G, Carballido J, Hellsten S, Schulze H, Mensink H. Guidelines on renal cell cancer. Eur Urol 2001;40:252-5. (Pubitemid 34701894)
5. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends fromthe Surveillance, Epidemiology, and End Results Program. J Urol 2006;176:2397-400. (Pubitemid 44755062)
6. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-4. (Pubitemid 44530728)
7. Lane BR, Tiong HY, Campbell SC, et al. Management of the adrenal gland during partial nephrectomy. J Urol 2009;181:2430-7.
8. Leibovitch I, Raviv G, Mor Y, Nativ O, Goldwasser B. Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. Urology 1995;46:316-20.
9. O'Malley RL, Godoy G, Kanofsky JA, Taneja SS. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 2009;181:2009-17.
10. Antonelli A, Cozzoli A, Simeone C, et al. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients. BJU Int 2006;97:505-8.
11. De Sio M, Autorino R, Di Lorenzo G, et al. Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. Urol Int 2003;71:361-7. (Pubitemid 37500527)
12. Gill IS, McClennan BL, Kerbl K, et al. Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. J Urol 1994;152:1082-5. (Pubitemid 24283438)
13. Kletscher BA, Qian J, Bostwick DG, Blute ML, Zincke H. Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. J Urol 1996;155:1844-6. (Pubitemid 26144068)
14. Moudouni SM, En-Nia I, Patard JJ, Manunta A, Guille F, Lobel B. Real indications for adrenalectomy in renal cell carcinoma. Scand J Urol Nephrol 2002;36:273-7. (Pubitemid 34921092)
15. Tsui KEH, Shvarts O, Barbaric Z, Figlin R, Dekernion JB, Belldegrun A. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol 2000;163:437-41. (Pubitemid 30060488)
16. Wunderlich H, Schlichter A, Reichelt O, et al. Real indications for adrenalectomy in renal cell carcinoma. Eur Urol 1999;35:272-6. (Pubitemid 29154830)
17. Campbell SC, Novick AC, Bukowski RM. Renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. ed. 9 Philadelphia, PA: Saunders Elsevier; 2007. p. 1567-637.
18. Novick AC. Open surgery of the kidney. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. ed. 9 Philadelphia, PA: Saunders Elsevier; 2007. p. 1686-758.
19. Siemer S, Lehmann J, Kamradt J, et al. Adrenal metastases in 1,635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol 2004;171:2155-9. (Pubitemid 38625424)
20. Miller DC, Ruterbusch J, Colt JS, et al. Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. J Urol 2010;184:2254-8.
21. Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010;58:398-406.
22. Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL, Blute ML. Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review. BJU Int 2003;91:775-9. (Pubitemid 36724056)
23. Saitoh H, Hida M, Nakamura K. Metastatic processes and a potential indication of treatment for metastatic lesions of renal adenocarcinoma. J Urol 1982;128:916-8. (Pubitemid 13211629)
24. von Knobloch R, Schrader AJ, Walthers EM, Hofmann R. Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasis. Urology 2009;73:333-6.